Literature DB >> 6593703

Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7.

A M Brown, J M Jeltsch, M Roberts, P Chambon.   

Abstract

We have shown previously that an increase in the level of accumulated pS2 mRNA is first detectable in MCF-7 cells after 3 hr of estradiol treatment. Using in vitro nuclear run-on transcription with nuclei prepared from MCF-7 cells grown in the presence of estradiol or in estradiol-stripped medium, we demonstrate here that expression of the pS2 gene is controlled by estrogen at the transcriptional level. Induction of transcription is a very early event that is already apparent within 15 min after addition of estradiol to the culture medium. In addition, pretreatment of the cells with the protein synthesis inhibitor cycloheximide does not prevent induction of pS2 gene transcription, indicating that it corresponds to a primary effect of estrogen. The pS2 gene in MCF-7 cells represents a unique example of a human gene whose transcription is directly controlled by estrogen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6593703      PMCID: PMC391920          DOI: 10.1073/pnas.81.20.6344

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Establishment and characterization of a cell line of human breast carcinoma origin.

Authors:  I Keydar; L Chen; S Karby; F R Weiss; J Delarea; M Radu; S Chaitcik; H J Brenner
Journal:  Eur J Cancer       Date:  1979-05       Impact factor: 9.162

2.  Quantitation of elongating form A and B RNA polymerases in chick oviduct nuclei and effects of estradiol.

Authors:  R F Cox
Journal:  Cell       Date:  1976-03       Impact factor: 41.582

3.  Effects of plasma estrogen sulfates in mammary cancer cells.

Authors:  F Vignon; M Terqui; B Westley; D Derocq; H Rochefort
Journal:  Endocrinology       Date:  1980-04       Impact factor: 4.736

4.  Estrogen receptor in a human cell line (MCF-7) from breast carcinoma.

Authors:  S C Brooks; E R Locke; H D Soule
Journal:  J Biol Chem       Date:  1973-09-10       Impact factor: 5.157

5.  Relation between soluble DNA-dependent RNA polymerase and "aggregate" RNA polymerase.

Authors:  P Chambon; M Ramuz; J Doly
Journal:  Biochem Biophys Res Commun       Date:  1965-10-26       Impact factor: 3.575

6.  The induction of ovalbumin and conalbumin mRNA by estrogen and progesterone in chick oviduct explant cultures.

Authors:  G S McKnight
Journal:  Cell       Date:  1978-06       Impact factor: 41.582

7.  Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing.

Authors:  K B Horwitz; W L McGuire
Journal:  J Biol Chem       Date:  1978-11-25       Impact factor: 5.157

8.  Transcriptional regulation of the ovalbumin and conalbumin genes by steroid hormones in chick oviduct.

Authors:  G S McKnight; R D Palmiter
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

9.  The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.

Authors:  M Lippman; G Bolan; K Huff
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

10.  Enrichment of estradiol-receptor complexes in a transcriptionally active fraction of chromatin from MCF-7 cells.

Authors:  R W Scott; F R Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

View more
  92 in total

1.  Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator.

Authors:  S Hayashi; K Hajiro-Nakanishi; Y Makino; H Eguchi; J Yodoi; H Tanaka
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

2.  The effects of histone acetylation on estrogen responsiveness in MCF-7 cells.

Authors:  M F Ruh; S Tian; L K Cox; T S Ruh
Journal:  Endocrine       Date:  1999-10       Impact factor: 3.633

3.  Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus.

Authors:  Christopher C Valley; Raphaël Métivier; Natalia M Solodin; Amy M Fowler; Mara T Mashek; Lindsay Hill; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

Review 4.  DNA microarray-based gene expression profiling of estrogenic chemicals.

Authors:  Ryoiti Kiyama; Yun Zhu
Journal:  Cell Mol Life Sci       Date:  2014-01-08       Impact factor: 9.261

5.  Estradiol and estrogen receptor-dependent stabilization of a minivitellogenin mRNA lacking 5,100 nucleotides of coding sequence.

Authors:  D A Nielsen; D J Shapiro
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

6.  Heterodimeric interaction between GKN2 and TFF1 entails synergistic antiproliferative and pro-apoptotic effects on gastric cancer cells.

Authors:  Olga Kim; Jung Hwan Yoon; Won Suk Choi; Hassan Ashktorab; Duane T Smoot; Suk Woo Nam; Jung Young Lee; Won Sang Park
Journal:  Gastric Cancer       Date:  2017-02-01       Impact factor: 7.370

7.  Independent transcriptional regulation of a single VL30 element by epidermal growth factor and activators of protein kinase C.

Authors:  K D Rodland; L L Muldoon; T H Dinh; B E Magun
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

8.  IQGAP1 binds to estrogen receptor-α and modulates its function.

Authors:  Huseyin H Erdemir; Zhigang Li; David B Sacks
Journal:  J Biol Chem       Date:  2014-02-18       Impact factor: 5.157

9.  Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genes.

Authors:  R A McClelland; D L Manning; J M Gee; E Anderson; R Clarke; A Howell; M Dowsett; J F Robertson; R W Blamey; A E Wakeling; R I Nicholson
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

10.  Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status.

Authors:  K Nesaretnam; R Stephen; R Dils; P Darbre
Journal:  Lipids       Date:  1998-05       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.